Most Recent
Zoetis has been ordered to pay Scidera’s costs of defending an unsuccessful summary dismissal application on a lump sum basis in a dispute over a bovine gene patent, with a judge rejecting its “premature” bid for a set-off.
Gaming company Light & Wonder will pay $190 million to settle Aristocrat’s litigation in Australia and the United States alleging it misappropriated trade secrets in developing two poker machines.
German drug maker Merck KGaA is fighting US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia, five years after their intellectual property spat was settled.
A judge has declined to order US-based animal genomics company Scidera to file a position statement in its bovine gene patent infringement suit and said she was “running out of patience” after unsuccessful strike-out and summary dismissal applications by the defendants.
Private equity firm Goldstone has lost its bid to disqualify a judge from a damages hearing after he found it liable for shareholder oppression of its managing director.
Animal drug company Zoetis has lost its bid for summary dismissal of claims that it infringed US-based animal genomics company Scidera's bovine gene patent, with a judge saying its novel arguments were not so clear-cut and needed to be worked out at trial.
Private equity firm Goldstone has lost its bid to lodge an appeal before damages are determined, after a judge found it invalidly terminated its managing director’s employment for standing in the way of a deal with her business partner’s son.
Private equity firm Goldstone has cited an "irretrievable breakdown" in the relationship between shareholders in seeking to appeal a ruling that found it liable for oppression.
A private equity fund is challenging a ruling that it acted in an “oppressive” and “unfairly prejudicial” way towards its managing director, who a judge found was invalidly sacked for standing in the way of a deal with her business partner’s son.
A group of Australia’s leading beef and dairy companies has failed to strike-out a suit alleging their genetic testing system for cattle infringes the patent of a US genomics company, with a judge rejecting objections to the phrase ‘further or in the alternative’.